{"id":"placebo-nacl-0-9-solution","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (rare)"},{"rate":null,"effect":"Fluid overload (with excessive volume)"}]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo saline contains sodium chloride at a concentration matching blood plasma osmolality, making it isotonic and suitable for intravenous or parenteral administration. It has no intrinsic therapeutic mechanism of action and is used as a control comparator in clinical trials or as a neutral vehicle for other medications. Any clinical benefit observed is attributable to placebo effect rather than pharmacological activity.","oneSentence":"Normal saline (0.9% NaCl solution) is an inert isotonic fluid that serves as a physiological vehicle for drug delivery or fluid replacement with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:10.150Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials"},{"name":"Vehicle for parenteral drug delivery"}]},"trialDetails":[{"nctId":"NCT07149649","phase":"PHASE2, PHASE3","title":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2026-07","conditions":"Metastatic NSCLC - Non-Small Cell Lung Cancer","enrollment":230},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07497646","phase":"NA","title":"Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2025-01-01","conditions":"Chronic Migraine Headache, Chronic Tension-type Headache","enrollment":290},{"nctId":"NCT07497399","phase":"PHASE2","title":"Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04","conditions":"Multiple Sclerosis","enrollment":120},{"nctId":"NCT07353307","phase":"PHASE3","title":"A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.","status":"RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2025-12-30","conditions":"Pain After Abdominal Surgery","enrollment":333},{"nctId":"NCT01915212","phase":"PHASE1","title":"Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2013-09-26","conditions":"Healthy Volunteers","enrollment":69},{"nctId":"NCT05139316","phase":"PHASE3","title":"A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"COMPLETED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-11-08","conditions":"Glycogen Storage Disease Type IA","enrollment":49},{"nctId":"NCT05072314","phase":"PHASE3","title":"Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial","status":"RECRUITING","sponsor":"Monash University","startDate":"2022-07-27","conditions":"Breast Cancer, Breast Cancer Female, Breast Conserving Surgery","enrollment":4300},{"nctId":"NCT07493577","phase":"PHASE1, PHASE2","title":"Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)","status":"NOT_YET_RECRUITING","sponsor":"Dr David Hasan, M.D.","startDate":"2026-07-23","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":82},{"nctId":"NCT07226258","phase":"PHASE3","title":"Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain","status":"RECRUITING","sponsor":"Saol Therapeutics Inc","startDate":"2025-11-07","conditions":"Osteoarthritis Knee Pain","enrollment":150},{"nctId":"NCT07491146","phase":"PHASE2","title":"Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain","status":"NOT_YET_RECRUITING","sponsor":"Yingyong Zhou,MD,PhD","startDate":"2026-03-25","conditions":"Pain After Abdominal Surgery","enrollment":200},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07486544","phase":"PHASE3","title":"Soaked Pharyngeal Packing Agents in Septoplasty","status":"RECRUITING","sponsor":"Assiut University","startDate":"2026-03-20","conditions":"Sore Throat","enrollment":90},{"nctId":"NCT07490457","phase":"NA","title":"Intraoperative Ketamine for Chronic Postoperative Pain After Open-Heart Surgery","status":"NOT_YET_RECRUITING","sponsor":"Bursa City Hospital","startDate":"2026-04-15","conditions":"Cardiac Anaesthesia, Chronic Pain, Post Operative Pain, Chronic","enrollment":100},{"nctId":"NCT05376566","phase":"NA","title":"Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2022-06-01","conditions":"Central Line-associated Bloodstream Infection (CLABSI)","enrollment":212},{"nctId":"NCT06862453","phase":"PHASE1","title":"Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults","status":"NOT_YET_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2026-03","conditions":"Malaria Falciparum","enrollment":58},{"nctId":"NCT07384052","phase":"PHASE1","title":"Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2026-02-20","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT07488988","phase":"PHASE2","title":"SCARFREE-001: Verteporfin for Scar Prevention","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2026-06","conditions":"Surgical Scar","enrollment":12},{"nctId":"NCT07488832","phase":"NA","title":"Intravenous Lidocaine Infusion in Lumbar Fusion Surgery","status":"NOT_YET_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-03-20","conditions":"Lumbar Fusion Surgery","enrollment":110},{"nctId":"NCT05184764","phase":"PHASE1, PHASE2","title":"Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia","status":"COMPLETED","sponsor":"Armata Pharmaceuticals, Inc.","startDate":"2022-04-26","conditions":"Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia","enrollment":56},{"nctId":"NCT06909565","phase":"PHASE4","title":"Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-07-23","conditions":"Percutaneous Coronary Intervention, Peripheral Endovascular Intervention","enrollment":6000},{"nctId":"NCT07207954","phase":"PHASE1","title":"Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Lifordi Immunotherapeutics, Inc.","startDate":"2025-10-06","conditions":"Rheumatoid Arthritis","enrollment":176},{"nctId":"NCT05996835","phase":"PHASE2","title":"Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-01-18","conditions":"Acute Kidney Injury Due to Sepsis","enrollment":320},{"nctId":"NCT07018700","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Episodic Migraine","enrollment":990},{"nctId":"NCT07018713","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Chronic Migraine","enrollment":780},{"nctId":"NCT03992404","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2019-09-16","conditions":"Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury","enrollment":603},{"nctId":"NCT04350138","phase":"PHASE2","title":"Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-12-29","conditions":"Gonococcal Infection","enrollment":2606},{"nctId":"NCT06652737","phase":"PHASE1","title":"Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2025-03-04","conditions":"Malaria Falciparum, Malaria Infection","enrollment":75},{"nctId":"NCT06229483","phase":"PHASE3","title":"The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies","status":"RECRUITING","sponsor":"Stephen Lownie","startDate":"2024-04-03","conditions":"Brain Tumor, Bleeding","enrollment":102},{"nctId":"NCT07482423","phase":"PHASE1, PHASE2","title":"XVIE to Treat Androgenetic Alopecia (AGA)","status":"NOT_YET_RECRUITING","sponsor":"Restore Biologics Holdings, Inc. dba Xtressé","startDate":"2026-05-01","conditions":"Androgenetic Alopecia","enrollment":30},{"nctId":"NCT06513546","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients","status":"NOT_YET_RECRUITING","sponsor":"PLL TX AUSTRALIA PTY LTD","startDate":"2026-04-08","conditions":"Amyotrophic Lateral Sclerosis, ALS","enrollment":153},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07462819","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of Intravenous Stemis™ in Elderly Subjects With Mild to Moderate Frailty Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Ji Yan Biomedical Co., Ltd.","startDate":"2026-04","conditions":"Frailty Syndrome","enrollment":12},{"nctId":"NCT07483346","phase":"PHASE1","title":"IASO-782 in Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"Shanghai IASO Biotechnology Co., Ltd","startDate":"2026-04-30","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":20},{"nctId":"NCT07058883","phase":"NA","title":"Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars","status":"RECRUITING","sponsor":"Nordberg Medical AB","startDate":"2026-03-13","conditions":"Acne Scars","enrollment":55},{"nctId":"NCT03304496","phase":"PHASE4","title":"Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.","status":"SUSPENDED","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2018-03-30","conditions":"Coronary Artery Disease","enrollment":1400},{"nctId":"NCT05831449","phase":"PHASE3","title":"CPL-01 in the Management of Postoperative Pain After Bunionectomy","status":"COMPLETED","sponsor":"Cali Pharmaceuticals LLC","startDate":"2023-05-22","conditions":"Bunion","enrollment":616},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT07479602","phase":"PHASE4","title":"Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2026-04","conditions":"Adenotonsillectomy, Children, Intranasal Administration","enrollment":160},{"nctId":"NCT06226805","phase":"PHASE2","title":"Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)","status":"RECRUITING","sponsor":"Basking Biosciences, Inc.","startDate":"2024-07-31","conditions":"Acute Ischemic Stroke","enrollment":228},{"nctId":"NCT05547464","phase":"PHASE1, PHASE2","title":"Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioNTech SE","startDate":"2023-07-31","conditions":"Tuberculosis","enrollment":497},{"nctId":"NCT07434024","phase":"NA","title":"Erector Spinae Plane Block for Acute Low Back Pain","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2026-03","conditions":"Non-specific Low Back Pain (NSLBP)","enrollment":300},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07474909","phase":"NA","title":"Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery","status":"NOT_YET_RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-04-01","conditions":"Hand Injuries and Disorders, Wrist Sprain","enrollment":150},{"nctId":"NCT04580563","phase":"NA","title":"Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-22","conditions":"Septic Shock, Coagulopathy, Disseminated Intravascular Coagulation","enrollment":60},{"nctId":"NCT07473453","phase":"NA","title":"Hyalouronic Acid and Periodontal Surgery","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2024-04-16","conditions":"Peridontal Disease","enrollment":26},{"nctId":"NCT04459117","phase":"PHASE2, PHASE3","title":"Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-10-29","conditions":"Patency of the Ductus Arteriosus, Acetaminophen, Extreme Prematurity","enrollment":804},{"nctId":"NCT06579690","phase":"PHASE3","title":"Use of Preoperative Sodium Bicarbonate Among Women With Obstructed Labor","status":"RECRUITING","sponsor":"Busitema University","startDate":"2025-05-06","conditions":"Obstructed Labor","enrollment":472},{"nctId":"NCT06556563","phase":"PHASE3","title":"EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"NovoCure GmbH","startDate":"2025-02-03","conditions":"Glioblastoma","enrollment":741},{"nctId":"NCT04838301","phase":"PHASE2","title":"Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-08-15","conditions":"Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases","enrollment":100},{"nctId":"NCT04468659","phase":"PHASE3","title":"AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eisai Inc.","startDate":"2020-07-14","conditions":"Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease","enrollment":1400},{"nctId":"NCT05491356","phase":"PHASE4","title":"Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2023-05-11","conditions":"Hematoma, Subdural, Fibrinolytic; Hemorrhage","enrollment":40},{"nctId":"NCT06685757","phase":"PHASE3","title":"A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)","status":"RECRUITING","sponsor":"Biogen","startDate":"2024-12-03","conditions":"Antibody-mediated Rejection","enrollment":120},{"nctId":"NCT07097012","phase":"PHASE4","title":"Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy","status":"RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2025-10-16","conditions":"RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination, Pregnancy","enrollment":60},{"nctId":"NCT06353529","phase":"PHASE4","title":"Postop Pain Management in Pituitary Tumour Patients","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2024-11-25","conditions":"Pituitary, Pain, Postoperative","enrollment":108},{"nctId":"NCT03172975","phase":"PHASE2","title":"Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2018-03-01","conditions":"Hookworm Infections","enrollment":39},{"nctId":"NCT07452146","phase":"PHASE2","title":"Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-06","conditions":"Alcohol Use Disorder, Inflammatory Response, Craving","enrollment":64},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT07440576","phase":"NA","title":"Effect of Paracervical Block on Postoperative Pain After vNOTES Uterosacral Ligament Suspension","status":"RECRUITING","sponsor":"Erkan Gol","startDate":"2026-03-09","conditions":"Pelvic Organ Prolapse (POP), Postoperative Pain","enrollment":58},{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT07465198","phase":"PHASE2","title":"Autologous Stem Cell Therapy in Patients With Multiple System Atrophy","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-09-01","conditions":"MSA - Multiple System Atrophy, MSA","enrollment":50},{"nctId":"NCT06925152","phase":"PHASE4","title":"COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block","status":"RECRUITING","sponsor":"University of Tennessee","startDate":"2025-07-15","conditions":"Complex Obstetric Surgery, Perioperative Pain Management, Cesarean Delivery","enrollment":120},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT07116343","phase":"PHASE4","title":"Intrapleural Ropivacaine Infusion in Cardiac Surgery","status":"RECRUITING","sponsor":"Saint Petersburg State University, Russia","startDate":"2025-10-22","conditions":"Cardiac Surgery, Coronary Artery Disease, Valvular Diseases","enrollment":116},{"nctId":"NCT03142334","phase":"PHASE3","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-06-09","conditions":"Renal Cell Carcinoma","enrollment":994},{"nctId":"NCT07214311","phase":"PHASE2, PHASE3","title":"Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty","status":"RECRUITING","sponsor":"Peptilogics","startDate":"2026-02-03","conditions":"Prosthetic-joint Infection","enrollment":240},{"nctId":"NCT07460518","phase":"PHASE4","title":"Tranexamic Acid for Bleeding Reduction During TURP Surgery","status":"NOT_YET_RECRUITING","sponsor":"Hamza Najout","startDate":"2026-03-15","conditions":"Benign Prostatic Hyperplasia, Transurethral Resection of the Prostate, Perioperative Bleeding","enrollment":80},{"nctId":"NCT07461103","phase":"PHASE2","title":"Effect of Topical Insulin on Healing Rate of Pemphigus Lesions","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-22","conditions":"Pemphigus Vulgaris, Skin Erosion, Autoimmune Blistering Disease","enrollment":20},{"nctId":"NCT07220109","phase":"PHASE3","title":"A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2025-10-29","conditions":"Respiratory Syncytial Virus Infections","enrollment":750},{"nctId":"NCT03221426","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-10-09","conditions":"Gastric Cancer, Gastroesophageal Junction Cancer","enrollment":1007},{"nctId":"NCT05116189","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-12-13","conditions":"Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms","enrollment":643},{"nctId":"NCT03306615","phase":"PHASE2","title":"Peripheral Modulation of Muscle Stiffness and Spasticity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-10-11","conditions":"Muscle Spasticity","enrollment":56},{"nctId":"NCT07457008","phase":"PHASE1","title":"Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2021-07-01","conditions":"Healthy Volunteers","enrollment":36},{"nctId":"NCT04362527","phase":"PHASE3","title":"Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2020-08-10","conditions":"Vasospasm","enrollment":370},{"nctId":"NCT03822637","phase":"PHASE4","title":"The Effect of NAC on Lung Function and CT Mucus Score","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-02-20","conditions":"Asthma","enrollment":4},{"nctId":"NCT07333859","phase":"PHASE4","title":"Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-02-11","conditions":"Duodenal Spasm, ERCP, Sedation","enrollment":120},{"nctId":"NCT04882241","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-07-29","conditions":"Gastric Cancer, Gastroesophageal Junction Cancer","enrollment":120},{"nctId":"NCT03847428","phase":"PHASE3","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-29","conditions":"Hepatocellular Carcinoma","enrollment":908},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT07401472","phase":"PHASE1","title":"Study of BW-50218 in Healthy Participants","status":"RECRUITING","sponsor":"Shanghai Argo Biopharmaceutical Co., Ltd.","startDate":"2026-02-25","conditions":"Healthy Participants Study","enrollment":60},{"nctId":"NCT05350774","phase":"PHASE2","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-07-10","conditions":"Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis","enrollment":45},{"nctId":"NCT07453069","phase":"PHASE2","title":"Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle","status":"NOT_YET_RECRUITING","sponsor":"Freya Biosciences ApS","startDate":"2026-04-15","conditions":"Vaginal Dysbiosis","enrollment":30},{"nctId":"NCT02362594","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-16","conditions":"Melanoma","enrollment":1019},{"nctId":"NCT07379580","phase":"PHASE2","title":"A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2026-02-20","conditions":"Mpox (Monkeypox), Smallpox, Orthopoxvirus Infection","enrollment":310},{"nctId":"NCT07445971","phase":"PHASE1","title":"A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.","status":"RECRUITING","sponsor":"ModeX Therapeutics, An OPKO Health Company","startDate":"2026-03","conditions":"COVID -19, COVID-19 (Prevention)","enrollment":80},{"nctId":"NCT07246863","phase":"PHASE2","title":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","status":"RECRUITING","sponsor":"CatalYm GmbH","startDate":"2025-10-07","conditions":"Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor","enrollment":131},{"nctId":"NCT05304715","phase":"PHASE2","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2022-04-13","conditions":"Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome","enrollment":44},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT06036602","phase":"PHASE2","title":"Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"Albert B. Sabin Vaccine Institute","startDate":"2024-07-15","conditions":"Ebola Sudan Virus Disease","enrollment":125},{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT07035301","phase":"NA","title":"Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2025-03-17","conditions":"Disease of Respiratory System","enrollment":153},{"nctId":"NCT07424001","phase":"PHASE4","title":"Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery","status":"COMPLETED","sponsor":"Mehmet Çiğdem","startDate":"2025-09-27","conditions":"Inguinal Hernia Unilateral, Delayed Neurocognitive Recovery, Postoperative Pain","enrollment":76},{"nctId":"NCT05696080","phase":"PHASE3","title":"Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-02-13","conditions":"Pneumococcal Infection","enrollment":518},{"nctId":"NCT07235046","phase":"PHASE2","title":"A Study of DII235 in Adults With Elevated Lipoprotein(a)","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-12-05","conditions":"Lipoprotein Disorder","enrollment":200},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110},{"nctId":"NCT07432737","phase":"NA","title":"One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures","status":"RECRUITING","sponsor":"University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje","startDate":"2026-02-17","conditions":"Hip Fractures","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Restricted","Liberal"],"phase":"marketed","status":"active","brandName":"Placebo (NaCl 0.9 % solution)","genericName":"Placebo (NaCl 0.9 % solution)","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo (NaCl 0.9% solution) is a solution used as a control in various clinical trials, including studies for genital herpes simplex type 2, anticoagulation, and intraocular pressure. It is a saline solution with no known oligosaccharide or heparin properties, as indicated by its modality and synonyms in ChEMBL.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}